Amelioration of Insulin Requirement in Patients Undergoing Duodenal Bypass for Reasons Other than Obesity Implicates Foregut Factors in the Pathophysiology of Type II Diabetes

Journal of the American College of Surgeons

Volumn 210, Issue 5, 2010, Pages 564-572

  Zervos, Emmanuel E ^a   Agle, Steven C ^a   Warren, Alex J ^a   Lang, Christina G ^a   Fitzgerald, Timothy L ^a   Dar, Moahad ^a,b   Rotondo, Michael F ^a   Pories, Walter J ^a,b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INSULIN SENSITIZING AGENT; ORAL ANTIDIABETIC AGENT; SULFONYLUREA; ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE COURSE; DISEASE DURATION; GASTRECTOMY BILLROTH II; GASTROINTESTINAL SURGERY; GENERAL CONDITION IMPROVEMENT; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT IDENTIFICATION; PREDICTOR VARIABLE; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; STOMACH BYPASS; SURGICAL INFECTION; TREATMENT INDICATION; WEIGHT REDUCTION; COHORT ANALYSIS; FEMALE; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; STOMACH;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BODY MASS INDEX; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRIC BYPASS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDIES; STOMACH; WEIGHT LOSS;

EID: 77952304122     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2009.12.025     Document Type: Article

References (20)

1. Narayan K.M., Boyle J.P., Geiss L.S., et al. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care 29 (2006) 2114-2116
2. Centers for Disease Control. National Diabetes Fact Sheet, 2007. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf Accessed January 6, 2010
3. Roglic G., Unwin N., Bennett P.H., et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 28 (2005) 2130-2135
4. Pories W.J., Caro J.F., Flickinger E.G., et al. The control of diabetes mellitus (NIDDM) in the morbidly obese with the Greenville Gastric Bypass. Ann Surg 206 (1987) 316-323
5. Pories W.J., MacDonald Jr. K.G., Morgan E.J., et al. Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr 55 (1992) 582S-585S
6. Schauer P.R., Burguera B., Ikramuddin S., et al. Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238 (2003) 467-484 discussion 484-485
7. Buchwald H., Estok R., Fahrbach K., et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. [see comment]. Am J Med 122 (2009) 248-256 e5
8. MacDonald Jr. K.G., Long S.D., Swanson M.S., et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1 (1997) 213-220
9. Pories W.J., Swanson M.S., MacDonald K.G., et al. Who would have thought it?. An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222 (1995) 339-350
10. Moo T.A., and Rubino F. Gastrointestinal surgery as treatment for type 2 diabetes. Curr Op Endocrinol Diabetes Obesity 15 (2008) 153-158
11. DePaula A.L., Macedo A.L., Rassi N., et al. Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc 22 (2008) 706-716
12. DePaula A.L., Macedo A.L., Rassi N., et al. Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus. Surg Endosc 22 (2008) 2670-2678
13. Geloneze B., Geloneze S.R., Fiori C., et al. Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal-jejunal exclusion. Obesity Surg 19 (2009) 1077-1083
14. 2. J Gastrointest Surg 12 (2008) 945-952
15. Noya G., Cossu M.L., Coppola M., et al. Biliopancreatic diversion preserving the stomach and pylorus in the treatment of hypercholesterolemia and diabetes type II: results in the first 10 cases. Obes Surg 8 (1998) 67-72
16. Schwarz A., Buchler M., Usinger K., et al. Importance of the duodenal passage and pouch volume after total gastrectomy and reconstruction with the Ulm pouch: prospective randomized clinical study. World J Surg 20 (1996) 60-66 discussion 66-67
17. Mingrone G. Role of the incretin system in the remission of type 2 diabetes following bariatric surgery. Nutrit Metabol Cardiovasc Dis 18 (2008) 574-579
18. Rubino F. Is type 2 diabetes an operable intestinal disease?. A provocative yet reasonable hypothesis. Diabetes Care 31 (2008) S290-S296
19. Maggard M.A., Shugarman L.R., Suttorp M., et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med 142 (2005) 547-559
20. Kadera B.E., Lum K., Grant J., et al. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss. Surg Obesity Rel Dis 5 (2009) 305-309